Skip to Content

The DNA Sequencing Revolution: Part 1 [Hot Topic]

Next-gen-sequencing

David Smith, Ph.D.
David Smith, Ph.D.

The cost and capacities of the various technologies for DNA sequencing have changed greatly since scientists sequenced the genome of Escherichia coli. Manufacturers have both the speed and capacity of the latest machines. In this discussion of DNA sequencers, David Smith, Ph.D., discusses both the strengths and weakness of the technology and available platforms.

Presenters and Credentials:
David Smith, Ph.D., Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic in Rochester, Minnesota

Kelley Luedke

Kelley Luedke

Kelley Luedke is a Marketing Channel Manager at Mayo Clinic Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her kitty, and exploring new foods.